Aerie Pharmaceuticals Inc

Most Recent

  • uploads///ecg electrocardiogram stethoscope
    Company & Industry Overviews

    Array BioPharma: Why Wall Street Analysts Are Positive

    Of the eight analysts tracking Array BioPharma in June, three recommended a “strong buy,” while five recommended a “buy.”

    By Daniel Collins
  • uploads///puzzle _
    Earnings Report

    What Analysts Recommend for Array BioPharma Stock

    As of August 15, analysts’ target price for ARRY is $23.57, which implies a ~71.7% return over the next 12 months based on the stock’s August 14 price of $13.73.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.